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LETTERS
receive isoniazid if their TB developed 
when they were young. In the present 
study, the resistant rate was lower for 
M. tuberculosis strains isolated from 
elderly persons than from younger 
adults. These fi ndings suggest that 
fi rst-line anti-TB medications still 
have good in vitro activity against M. 
tuberculosis strains in elderly patients.
In contrast to the study by Vinnard 
et al. (1), our results showed that 
isoniazid-resistant M. tuberculosis 
was signifi cantly less likely to be 
isolated from nonrespiratory than from 
respiratory specimens. The reasons for 
this fi nding are unclear. Continuous 
monitoring of antimicrobial drug 
resistance among M. tuberculosis 
isolates isolated from various body 
sites needs to be incorporated into any 
TB surveillance program.
Gathering data on drug resistance 
rates is a major aspect of the global TB 
control program. Clinicians must have 
knowledge of local epidemiology, and 
mycobacteriology laboratories should 
maintain up-to-date information on 
drug susceptibility test profi les of 
local M. tuberculosis isolates.
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Novel 
Mycobacterium 
Species in 
Seahorses with 
Tail Rot
To the Editor: Seahorses 
(Hippocampus guttulatus and H. 
hippocampus) with signs of tail rot 
disease (lethargy, lack of appetite, 
white spots on the skin, and necrotic 
tail lesions) were collected from 
aquaria at the Institute of Marine 
Research, Spain, during March 
2007 through May 2009 (online 
Appendix Figure, www.cdc.gov/
EID/content/17/9/101289-appF.
htm). Microscopic examination 
of cutaneous lesions after Ziehl-
Neelsen staining disclosed acid-
fast bacilli. Microbiologic analysis 
showed unidentifi ed Mycobacterium 
strains. Subsequently, we used PCR 
amplifi cation of repetitive bacterial 
DNA elements to group the strains (1). 
The results showed an identical PCR 
pattern for the strains; thus, we selected 
strain BFLP-6T for analysis. On the 
basis of phenotypic and genotypic 
data, we consider the unknown acid-
fast bacillus to represent a novel 
species of the genus Mycobacterium, 
for which the name M. hippocampi sp. 
nov. is proposed.
Extraction and amplifi cation of 
genomic DNA for 16S rRNA sequence 
analysis were conducted as described 
(2), and the RNA polymerase B (rpoB) 
gene was amplifi ed and sequenced 
as described by Adékambi et al. (3). 
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Table. Factors associated with isoniazid resistance among Mycobacterium tuberculosis
isolates, National Taiwan University Hospital, Taiwan, 2000–2010* 
Factor 
No.
infections 
No. isoniazid- 
resistant infections 
Resistance
rate OR (95% CI) 
Patient age, y 
 <14 42 2 4.76 0.32 (0.08–1.23) 
 14 to <24 241 22 9.13 0.64 (0.42–1.07) 
 24 to <34 342 36 10.53 0.75 (0.48–1.18) 
 34 to <44 384 52 13.54 Reference 
 44 to <54 490 56 11.43 0.82 (0.55–1.23) 
 54 to <64 609 70 11.49 0.83 (0.57–1.22) 
 64 to <74 845 96 11.36 0.82 (0.57–1.17) 
 74 to <84 986 85 8.62 0.60 (0.42–0.87) 
 84 350 28 8.00 0.56 (0.34–0.90) 
Patient sex 
 F 1,356 128 9.44 0.85 (0.69–1.06) 
 M 2,933 319 10.88 Reference 
Pulmonary tuberculosis 
 No 772 56 7.25 0.63 (0.47–0.84) 
 Yes 3,517 391 11.12 Reference 
*OR, odds ratio; CI, confidence interval. 
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Sequences obtained were compared 
against the sequences available in 
the GenBank, EMBL, and DDBJ 
databases obtained from the National 
Center for Biotechnology Information 
by using the BLAST program (4). 
Phylogenetic analysis were performed 
by using MEGA version 4.0 (5) 
after multiple alignments of data by 
ClustalX (6). Distances (distance 
options according to the Kimura 
2-parameter model) and clustering 
with the neighbor-joining method 
were determined by using bootstrap 
values for 1,000 replications.
The 16S rRNA sequence of strain 
BFLP-6T was a continuous stretch 
of 1,473 bp (GenBank accession no. 
FN430736). Sequence similarity 
calculations after a neighbor-joining 
analysis indicated that the closest 
relatives of strain BFLP-6T were 
M. fl avescens (98.26%), M. goodii 
(98.01%), M. duvalii (97.94%), 
M. smegmatis (97.92%), and M. 
novocastrense (97.86%) (Figure). 
Similar results were obtained for 
strain BFLP-6T when the maximum-
parsimony algorithm was used. The 
rpoB gene has also been proposed 
as a useful marker for inferring 
bacterial phylogeny (7,8). A pair-
wise analysis of the rpoB sequence of 
strain BFLP-6T (GenBank accession 
no. FR775976) showed low levels of 
similarity (<89.8%) with other species 
of the genus Mycobacterium. The G 
+ C content of DNA, as measured by 
the thermal denaturation method, was 
66.7 mol%.
Strain BFLP-6T was found to 
consist of gram-positive–staining, 
aerobic, acid-alcohol–fast, nonmotile, 
and nonsporulating cells. A scanning 
electron micrograph showed that strain 
BFLP-6T is irregular, rod-shaped, 
≈1.2–1.4 μm in length, and 0.4 μm 
in diameter. Colonies on Lowenstein-
Jensen medium supplemented with 
1.5% (wt/vol) sodium chloride were 
orange after incubation at 25°C for 
5 days. The colonies were positive 
for catalase, glucose fermentation, 
arginine dihydrolase, urease, and 
aesculin, and assimilation of glucose, 
mannitol, potassium gluconate, and 
malate. The colonies were negative 
for nitrate reduction to nitrite, oxidase, 
indole production, gelatin hydrolysis, 
N-acetyl-D-glucosamine; and 
assimilation of arabinose, mannose, 
maltose, caprate, adipate, citrate, and 
phenylacetate. The major fatty acids 
were C18:1ω9c, C16:0, and C16:1ω6c. 
Mycolic acids included α-mycolates, 
keto-mycolates, and nonhydroxylated 
fatty acid methyl esters.
In addition, strain BFLP-6T showed 
resistance to isoniazid, thiophene-2-
carboxylic hydrazide, hydroxylamine, 
thiacetazone, and picrate. However, 
the strain exhibited susceptibility to 
ciprofl oxacin, clarithromycin, and 
rifampin. The type strain BFLP-6T 
has been deposited in the German 
Collection of Microorganisms and 
Cell Cultures, under reference DSM 
45391T; and in the Belgian Coordinated 
Collections of Microorganisms under 
reference LMG 25372T.
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Figure. Neighbor-joining phylogenetic tree constructed from 16S rRNA gene sequences, 
showing the position of strain BFLP-6T (in boldface) among other Mycobacterium 
species. Numbers at node indicate bootstrap values (expressed as percentages of 
1,000 replications); only values >50% are given. Mycobacterium leprae TN was used 
as an outgroup. Scale bar indicates 0.01 substitutions per nucleotide position. GenBank 
accession numbers are in parentheses.
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Mycoplasma leachii 
sp. nov. in Calves, 
China
To the Editor: Mycoplasma 
leachii sp. nov., a new species 
designation for Mycoplasma sp. 
bovine group 7 (1), was initially 
isolated from joint fl uids of arthritic 
calves in southern Queensland, 
Australia, and its pathogenicity was 
established by experimental infection 
(2). It was represented by the type 
strain PG50. Subsequently, M. leachii 
was reported infrequently as a cause of 
polyarthritis in calves and mastitis in 
cows; the pathogen was also isolated 
from aborted fetuses and pneumonic 
bovine lungs (3–6) and from small 
ruminant hosts (7).
M. leachii is one of 5 recognized 
members of the M. mycoides cluster, 
which comprises 3 species (1). Most 
notable are M. mycoides subsp. 
mycoides small colony and M. 
capricolum subsp. capripneumoniae, 
the etiologic agents of contagious 
bovine and caprine pleuropneumonia, 
which are listed by the World 
Organisation for Animal Health 
as notifi able animal diseases. The 
M. mycoides subsp. capri and M. 
capricolum subsp. capricolum cause 
various symptoms in small ruminants 
(8). Strains of M. leachii that cause 
mastitis and polyarthritis in cattle 
are serologically distinct from other 
bovine Mycoplasma spp. (9). Most 
reported isolates of M. leachii were 
detected in Australia. We report the 
isolation of M. leachii in cattle in 
China.
During January–May 2009, 
severe polyarthritis was observed in 
≈100% of ≈350 female calves at the 
central calf rearing unit of a farm 
in Helongjiang Province, People’s 
Republic of China. Clinical signs 
were noticed at ≈3–5 days of age, 
with severity gradually increasing 
over the next 2 days. At that time, the 
carpal and tarsal joints were greatly 
enlarged because of accumulation 
of intraarticular fl uid. Ampicillin, 
sulfonamide, and streptomycin 
antimicrobial drug regimens for 
polyarthritis were ineffective. 
Approximately 100 calves died during 
the outbreak; the remaining calves 
recovered irrespective of treatment, 
but permanent disfi gurement of the 
appendicular skeleton was evident. 
The disfi gurement led to the calves 
being culled.
Necropsy was conducted on the 
calves that died during the outbreak, 
and gross and histopathologic fi ndings 
similar to those described (2,3) were 
observed. Nearly all diarthroidal 
joints were enlarged and contained 
yellow-gray turbid synovial fl uid and 
large yellow fi brin clots. The synovial 
membranes were slightly thickened, 
congested, and had some villous 
proliferation. Histologic examination 
of the affected articulations 
found severe, diffuse, subacute 
arthrosynovitis and bursitis.
Routine bacterial culture of 2 joint 
fl uid samples collected aseptically 
from different animals showed no 
bacterial growth. Mycoplasma spp.
infection was suspected, and the 
samples were forwarded to the 
laboratory for specifi c culture; 2 were 
positive for Mycoplasma spp. These 
isolates were designated GN407 and 
GN408.
The presence of M. leachii in 
joint fl uids and Mycoplasma spp.–
positive cultures was detected by PCR 
with the partial lppA gene amplifi ed 
with a protocol modifi ed from the 
method described by Frey et al. (10) 
and amplifi cation of the complete 
16S rRNA gene was performed 
by using the primers 16S-upper
5 ′ -AAAATGAGAGTTTGATCC
TGG-3′ and 16S-lower 5′-AGAAAG
GAGGTGATCCATCCG-3′. The 
primers were designed on the basis 
of the 16S rRNA gene sequence of 
M. leachii PG50 (U26054). PCR 
products were sequenced directly in 
both directions. Sequence analyses 
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